Good morning. What happens to an organization after it achieves a moonshot? That has been Albert Bourla’s reality, post-COVID. As the CEO of Pfizer, a company he first joined in 1993, Bourla—a ...

Pfizer CEO ‌Albert ‌Bourla on Monday ​flagged issues with the leadership of ‌the ⁠U. Food and ⁠Drug Administration's vaccine ...

Pfizer CEO Albert Bourla says he used extreme team-motivating tactics to meet seemingly impossible deadlines during the COVID-19 pandemic. Specifically, his team was tasked with creating a vaccine to ...

Pfizer Chairman and CEO Albert Bourla joins 'Mad Money' host Jim Cramer at the JPMorgan Health Care Conference to talk its weight loss offerings, its guidance for the upcoming year, and more. Got a ...

Pfizer/BioNTech plans to ask for authorization of a COVID-19 vaccine for some children under 12 soon, bringing the US one step closer to offering protection to a population that has grown particularly ...

Pfizer Inc. (NYSE: PFE) CEO Albert Bourla sharply criticized Robert F. Kennedy's views on vaccines, calling them "anti-science." He suggested that meaningful progress on immunization policy would ...

When Pfizer CEO Albert Bourla asked his employees to compress years of vaccine development and manufacturing into months, he knew the first reaction would be resistance. Faced with a task that seemed ...

SAN FRANCISCO, Jan 12 (Reuters) - Pfizer (PFE.N), opens new tab is preparing for a consumer market for obesity drugs on par with the booming business it saw after it launched erectile dysfunction drug ...

Pfizer is spinning off a big chunk of the company, culminating a rare tear of major deals aimed at reshaping the drugmaker into a slimmed-down version with faster, more-sustainable growth. The biggest ...

By Mariam Sunny March 2 (Reuters) - Pfizer CEO Albert Bourla said the company "has a problem" with the U.S. Food and Drug Administration's biologics and vaccines chief, Vinay Prasad, in response to a ...